{"paper_id":"7091ed7d-7e95-4405-a140-9deae8609713","body_text":"The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:\nDr. Celine Bafort, gynecologist, UZ Leuven:\nReceived sponsorship by Gedeon Richter and Ferring Pharmaceuticals to travel and attend scientific meetings\nDr. Celine Blank:\nReceived sponsorship from Gedeon-Richter, Bridea, Erbe, Goodlife, Memidis Pharma B.v., Ferring Pharmaceuticals and Samsung healthcare\nDr. Brecht Geysenbergh - Member advisory board Gedeon-Richter - Received sponsorship from Gedeon-Richter, Theramex, Merck, Ferring and Goodlife\nMember advisory board Gedeon-Richter\nReceived sponsorship from Gedeon-Richter, Theramex, Merck, Ferring and Goodlife\nDr. Jasper Verguts, gynecologist, Jessa Hospital Hasselt: - Member national and international advisory board Gedeon Richter - Received sponsorship form Theramex and Merck.\nMember national and international advisory board Gedeon Richter\nReceived sponsorship form Theramex and Merck.\nProf. Dr. Carla Tomassetti, gynecologist, UZ Leuven: - Deputy director of JMIG (paid to institution, no private revenue) - Received sponsoring by Merck SA for a clinical fellowship programme for reproductive endocrinology (paid to institution, no private revenue), consulting fees from Gedeon Richter and Merck SA (paid to institution, no private revenue), honoraria for lectures/presentations by Gedeon Richter, Merck SA and Ferring Pharmaceutical (paid to institution, no private revenue), sponsoring by Gedeon Richter, Merck SA and Ferring to travel and attend scientific meetings.\nDeputy director of JMIG (paid to institution, no private revenue)\nReceived sponsoring by Merck SA for a clinical fellowship programme for reproductive endocrinology (paid to institution, no private revenue), consulting fees from Gedeon Richter and Merck SA (paid to institution, no private revenue), honoraria for lectures/presentations by Gedeon Richter, Merck SA and Ferring Pharmaceutical (paid to institution, no private revenue), sponsoring by Gedeon Richter, Merck SA and Ferring to travel and attend scientific meetings.\nThe other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.\nThese conflicts of interest had no impact on the development of this clinical guidance.","source_license":"CC0","license_restricted":false}